<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04813666</url>
  </required_header>
  <id_info>
    <org_study_id>MansouraU LAM</org_study_id>
    <nct_id>NCT04813666</nct_id>
  </id_info>
  <brief_title>Lipoarabinomannan (LAM) in Urine for Diagnosis of Pulmonary Tuberculosis in HIV Patients</brief_title>
  <official_title>Role of Detection of Lipoarabinomannan (LAM) in Urine for Diagnosis of Pulmonary Tuberculosis in HIV Patients; Egyptian Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A diagnostic validity study in which urinary LAM was done in seropositive HIV patients with&#xD;
      symptoms suggestive of TB who were included and investigated with battery of tests to reach&#xD;
      the final diagnosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A diagnostic validity study in which urinary LAM was done in seropositive HIV patients with&#xD;
      symptoms suggestive of TB who were included and investigated with battery of tests to reach&#xD;
      the final diagnosis.&#xD;
&#xD;
      The study was conducted at Mansoura Fever Hospital in collaboration with the Chest Department&#xD;
      and Clinical Pathology Department, Mansoura University, Egypt, from January 2015 to October&#xD;
      2016.&#xD;
&#xD;
      Ethical approval had been obtained from Medical Research Ethics Committee of Faculty of&#xD;
      Medicine, Mansoura University (code no: MD/138). Approval from Egyptian Ministry of Health&#xD;
      was taken (No: 1-2016/18). Patients signed their written consents after detailed explanation&#xD;
      of the study protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">October 1, 2016</completion_date>
  <primary_completion_date type="Actual">August 1, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>positive for TB</measure>
    <time_frame>day 1</time_frame>
    <description>Concentration of urinary LAM was done in seropositive HIV patients</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">214</enrollment>
  <condition>TB - Tuberculosis HIV</condition>
  <arm_group>
    <arm_group_label>TB group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non TB group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Urinary LAM ELISA:</intervention_name>
    <arm_group_label>Non TB group</arm_group_label>
    <arm_group_label>TB group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The study included seropositive HIV patients with a new diagnosis of either pulmonary&#xD;
             or extra-pulmonary TB, and also included patients who were presented by symptoms&#xD;
             suggestive for tuberculosis, changes in chest X ray that not improved by full course&#xD;
             of antibiotics or positive tuberculin test â‰¥ 5 mm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients on anti-TB drugs or negative screening for sero-positive HIV patients were&#xD;
             excluded from the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Assem Hewidy</investigator_full_name>
    <investigator_title>assistant professor of chest medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>NO plan</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

